Development of an insect cell-based adeno-associated virus packaging cell line employing advanced Rep gene expression control system

被引:10
作者
Moreno, Fiona [1 ]
Lip, Florence [1 ]
Rojas, Hugo [1 ]
Anggakusuma [1 ]
机构
[1] UniQure Bopharm BV, Dept Res & Dev, NL-1105 BP Amsterdam, Netherlands
关键词
VECTORS; ENHANCER; IE1; BINDING; GENOME;
D O I
10.1016/j.omtm.2022.10.015
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The insect cell-based baculovirus expression vector (BEV) sys-tem is a leading platform for scalable production of adeno-associated viruses (AAVs). The previously described One-Bac system consists of an insect packaging cell line harboring the AAV Rep and Cap genes and a BEV carrying the transgene and AAV inverted terminal repeats. Here we describe a new sys-tem where we successfully translated the molecular design of a double AAV Rep expression cassette to inducible plasmid vectors. These optimized plasmid vectors employ non -canoni-cal late promoters and alternative start codons that alleviate promoter-promoter competition. Because too much Rep expression can be toxic to the host cells, tighter regulation of AAV Rep expression is warranted. This has been achieved by adopting alternate baculovirus homologous region enhancers. Inoculation of the resultant stable insect Rep packaging cell line by a recombinant BEV produced high-titer recombinant AAV (rAAV) preparations (1 x 1011 genome copies/mL). Sequential batch reactor experiments indicate that this system is amenable to large-scale AAV production. We generated an insect packaging cell line that employs an optimized Rep gene control system, ensuring stable and appropriate Rep expres-sion. This platform produces potent and high-yield AAV particles and demonstrates potential for scale up.
引用
收藏
页码:391 / 403
页数:13
相关论文
共 33 条
[31]  
Weitzman MD, 2011, METHODS MOL BIOL, V807, P1, DOI 10.1007/978-1-61779-370-7_1
[32]   Development of Versatile and Flexible Sf9 Packaging Cell Line-Dependent OneBac System for Large-Scale Recombinant Adeno-Associated Virus Production [J].
Wu, Yang ;
Mei, Ting ;
Jiang, Liangyu ;
Han, Zengpeng ;
Dong, Ruping ;
Yang, Tian ;
Xu, Fudiang .
HUMAN GENE THERAPY METHODS, 2019, 30 (05) :172-183
[33]   Endgame: Glybera Finally Recommended for Approval as the First Gene Therapy Drug in the European Union [J].
Ylae-Herttuala, Seppo .
MOLECULAR THERAPY, 2012, 20 (10) :1831-1832